Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Nitazoxanide advances in phase II

March 15, 1996

Neupogen approved for AIDS-related indication

March 15, 1996

Alpha Leukoferon to be tested in HIV-infected hemophiliacs

March 15, 1996

Cidofovir approval recommended by committee

March 15, 1996

MDX-240 promising in HIV trials

March 15, 1996

Nagrestip tested for use in HIV

March 15, 1996

Cel-Sci's AIDS vaccine demonstrates efficacy

March 15, 1996

British Biotech abandons HIV candidate

March 15, 1996

FDA approves HIV drug

March 15, 1996

Avid may license DMP-450 from DuPont Merck

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...